De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy
Molecular Case Studies · 2023
DOI: 10.1101/mcs.a006293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Case Studies, 2023. Verfasst von Jagadish Chandrabose Sundaramurthi und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA. Hauptthemen laut MEDLINE: Cerebral Palsy, Intellectual Disability, Nervous System Malformations, TRPM Cation Channels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
We identified a de novo heterozygous transient receptor potential cation channel subfamily M (melastatin) member 3 ( TRPM3 ) missense variant, p.(Asn1126Asp), in a patient with developmental delay and manifestations of cerebral palsy (CP) using phenotype-driven prioritization analysis of whole-genome sequencing data with Exomiser. The variant is localized in the functionally important ion transport domain of the TRPM3 protein and predicted to impact the protein structure. Our report adds TRPM3 to the list of Mendelian disease–associated genes that can be associated with CP and provides further evidence for the pathogenicity of the variant p.(Asn1126Asp).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.
- Shriners Children's Northern California, Sacramento, California 95817, USA.
- Shriners Children's, Portland, Oregon 97239, USA.
- Shriners Children's Genomics Institute, Tampa, Florida 33612, USA.
- Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, California 95817, USA.
- The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA; peter.robinson@jax.org.
ORCID-Profile: Jagadish Chandrabose Sundaramurthi, Anita M Bagley, Hannah Blau, Leigh Carmody, Amy Crandall, Daniel Danis, Michael A Gargano, Mallory Shingle, Jon R Davids, Peter N Robinson
Förderung
- NICHD NIH HHS
Zitieren
APA
Sundaramurthi, J. C., Bagley, A. M., Blau, H., Carmody, L., Crandall, A., Danis, D., Gargano, M. A., Gustafson, A. G., Raney, E. M., Shingle, M., Davids, J. R., & Robinson, P. N. (2023). De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy. Molecular Case Studies. https://doi.org/10.1101/mcs.a006293
Vancouver
Sundaramurthi JC, Bagley AM, Blau H, Carmody L, Crandall A, Danis D, et al. De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy. Molecular Case Studies. 2023. doi:10.1101/mcs.a006293
BibTeX
@article{Sundaramurthi2023,
author = {Sundaramurthi, Jagadish Chandrabose and Bagley, Anita M and Blau, Hannah and Carmody, Leigh and Crandall, Amy and Danis, Daniel and Gargano, Michael A and Gustafson, Anxhela Gjyshi and Raney, Ellen M and Shingle, Mallory and Davids, Jon R and Robinson, Peter N},
title = {De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy},
journal = {Molecular Case Studies},
year = {2023},
doi = {10.1101/mcs.a006293}
}
EUVIMED